Mission
Law
Pub. L. No. 115-263, 132 Stat. 3673, codified in relevant part at 21 U.S.C. § 355 note
Section 3 of this Act requires certain agreements involving biosimilar biological drugs to be filed with the antitrust agencies in the same way certain agreements involving generic drugs must be filed under the Medicare Prescription Drug, Improvement, and Modernization Act of 2003.